Literature DB >> 15993267

Losses of 1p and chromosome 14 in renal oncocytomas.

László Füzesi1, Derk Frank, Christian Nguyen, Rolf-Hermann Ringert, Henning Bartels, Bastian Gunawan.   

Abstract

We performed cytogenetic analyses of 8 renal oncocytomas to identify chromosomal regions involved in the tumorigenesis of oncocytomas. All cases showed chromosomal findings corresponding to established cytogenetic subsets of renal oncocytomas: 3 cases with normal karyotypes, 1 case with rearrangement of 11q, and 4 cases with losses of chromosome 14. In the latter cytogenetic subgroup, monosomy 14 was additionally accompanied by either monosomy 1 in 2 cases or loss of 1p in a third case, providing insights in the cytogenetic evolution of this subgroup.

Entities:  

Mesh:

Year:  2005        PMID: 15993267     DOI: 10.1016/j.cancergencyto.2004.12.010

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  4 in total

1.  Renal oncocytoma: a comparative clinicopathologic study and fluorescent in-situ hybridization analysis of 73 cases with long-term follow-up.

Authors:  Marie Dvorakova; Rajiv Dhir; Sheldon I Bastacky; Kathleen M Cieply; Marie B Acquafondata; Carol R Sherer; Tracy L Mercuri; Anil V Parwani
Journal:  Diagn Pathol       Date:  2010-05-24       Impact factor: 2.644

Review 2.  Emerging glioneuronal and neuronal tumors: case-based review.

Authors:  So Dug Lim; Seong Ik Kim; Jin Woo Park; Jae Kyung Won; Seung-Ki Kim; Ji Hoon Phi; Chun-Kee Chung; Seung-Hong Choi; Hongseok Yun; Sung-Hye Park
Journal:  Brain Tumor Pathol       Date:  2022-01-20       Impact factor: 3.298

3.  Differential expression of a new isoform of DLG2 in renal oncocytoma.

Authors:  Dmitry Zubakov; Zorica Stupar; Gyula Kovacs
Journal:  BMC Cancer       Date:  2006-04-26       Impact factor: 4.430

Review 4.  Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms.

Authors:  Ning Yi Yap; Retnagowri Rajandram; Keng Lim Ng; Jayalakshmi Pailoor; Ahmad Fadzli; Glenda Carolyn Gobe
Journal:  Biomed Res Int       Date:  2015-09-13       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.